Status:

WITHDRAWN

Study of Supplementation of Antidepressants With Fish Oil to Improve Time to Clinical Response

Lead Sponsor:

University of Virginia

Conditions:

Major Depressive Disorder

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study will be a randomized controlled trial set in an outpatient clinic, involving patients with major depressive disorder, who will be treated with antidepressant therapy, which will be individu...

Eligibility Criteria

Inclusion

  • Diagnosis of Major Depressive Disorder.
  • Allowed comorbidities: Dysthymia, Anxiety Disorders.
  • 18 years old or older.
  • Males + Females.
  • English-speaking.
  • Women of reproductive age must be on adequate birth control, either oral contraceptives or using condoms or other barrier methods with spermicidal agents.
  • Subjects may be undergoing psychotherapy, but must maintain current psychotherapy status. Must not start therapy if not already in therapy. If in therapy, must have received at least 6 sessions prior to entering the study.
  • Subjects may continue taking herbals or supplements during the study, but they may not start any new herbals or supplements during the study.

Exclusion

  • 2 or more failed trials of antidepressants (adequate dose and duration, and documented).
  • Substance dependence in the past 6 months.
  • Current substance use or abuse (MJ, benzodiazepines, narcotics). If BZD use, patient must be tapered off and wait 1 month before being included in the trial.
  • Psychosis.
  • Bipolar Affective Disorder Type I, II or NOS.
  • Pregnancy (current or planned).
  • Unstable medical illness (pt has to be stable for at least 3 months, and may be excluded per investigator discretion).
  • Dementia.
  • Mental retardation.
  • Traumatic Brain Injury.
  • History of Stroke.
  • History of seizure disorder.
  • Electroconvulsive therapy within past 6 months.
  • If, at the investigator's discretion, it is suspected that the subject will likely not comply with the study protocol.
  • Imminent risk for suicide.

Key Trial Info

Start Date :

September 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2010

Estimated Enrollment :

78 Patients enrolled

Trial Details

Trial ID

NCT00963196

Start Date

September 1 2009

End Date

May 1 2010

Last Update

June 4 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UVA Psychiatry Outpatient Clinic

Charlottesville, Virginia, United States, 22908